12:00 AM
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Irinotecan Bead: Phase IIb started

Biocompatibles began the Phase IIb portion of an open-label, U.S. Phase IIa/b trial to compare FOLFOX and Avastin bevacizumab with or without DEBIRI...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >